ArticleJournal of orthopaedic surgery and research2022

Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial.

Jun-Young Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.